Pharma Industry News

October 29 2024 – Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales

Written by David Miller

Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years
GSK to pay $300M to license drug it sees as potential lupus treatment
How AZ’s respiratory wins are ramping up for a bigger prize in COPD
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image: Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]